Lineage, Inc. Common Stock (LINE)vsRithm Capital Corp. (RITM)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
RITM
Rithm Capital Corp.
$9.74
+0.83%
REAL ESTATE · Cap: $5.51B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 24% more annual revenue ($5.37B vs $4.32B). RITM leads profitability with a 10.8% profit margin vs -3.1%. RITM earns a higher WallStSmart Score of 49/100 (D+).
LINE
Avoid35
out of 100
Grade: F
RITM
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+83.4%
Fair Value
$64.48
Current Price
$9.74
$54.74 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Attractively priced relative to earnings
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Weak financial health signals
Earnings declined 93.2%
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : RITM
The strongest argument for RITM centers on Price/Book, P/E Ratio.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : RITM
The primary concerns for RITM are Piotroski F-Score, EPS Growth, Altman Z-Score. Debt-to-equity of 4.72 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while RITM is a value play — different risk/reward profiles.
RITM carries more volatility with a beta of 1.11 — expect wider price swings.
RITM is growing revenue faster at 9.7% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
RITM scores higher overall (49/100 vs 35/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Rithm Capital Corp.
REAL ESTATE · REIT - MORTGAGE · USA
Rhythm Capital Corp. The company is headquartered in New York, New York.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?